Loss of Cav3.1 channels also worsens bradycardia-related mortality, increases bradycardia-associated adverse remodeling, and enhances the risk of malignant ventricular tachyarrhythmia following atrioventricular block. This evidence concerns the gene CACNA1G and atrioventricular block.